{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:08:43Z","timestamp":1792886923733,"version":"4.5.0"},"reference-count":179,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Primary aldosteronism (PA) is characterized by excess production of aldosterone from the adrenal glands and is the most common and treatable cause of secondary hypertension. Aldosterone is a mineralocorticoid hormone that participates in the regulation of electrolyte balance, blood pressure, and tissue remodeling. The excess of aldosterone caused by PA results in an increase in cardiovascular and cerebrovascular complications, including coronary artery disease, myocardial infarction, stroke, transient ischemic attack, and even arrhythmia and heart failure. Endothelial dysfunction is a well-established fundamental cause of cardiovascular diseases and also a predictor of worse clinical outcomes. Accumulating evidence indicates that aldosterone plays an important role in the initiation and progression of endothelial dysfunction. Several mechanisms have been shown to contribute to aldosterone-induced endothelial dysfunction, including aldosterone-mediated vascular tone dysfunction, aldosterone- and endothelium-mediated vascular inflammation, aldosterone-related atherosclerosis, and vascular remodeling. These mechanisms are activated by aldosterone through genomic and nongenomic pathways in mineralocorticoid receptor-dependent and independent manners. In addition, other cells have also been shown to participate in these mechanisms. The complex interactions among endothelium, inflammatory cells, vascular smooth muscle cells and fibroblasts are crucial for aldosterone-mediated endothelial dysregulation. In this review, we discuss the association between aldosterone and endothelial function and the complex mechanisms from a molecular aspect. Furthermore, we also review current clinical research of endothelial dysfunction in patients with PA.<\/jats:p>","DOI":"10.3390\/ijms20205214","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T11:37:55Z","timestamp":1571657875000},"page":"5214","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Endothelial Dysfunction in Primary Aldosteronism"],"prefix":"10.3390","volume":"20","author":[{"given":"Zheng-Wei","family":"Chen","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10002, Taiwan"},{"name":"Cardiovascular center, National Taiwan University Hospital, Taipei 10002, Taiwan"},{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin 64041, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsuan","family":"Tsai","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10002, Taiwan"},{"name":"Cardiovascular center, National Taiwan University Hospital, Taipei 10002, Taiwan"},{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Jin-Shan Branch, New Taipei City 20844, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ting","family":"Pan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10002, Taiwan"},{"name":"Cardiovascular center, National Taiwan University Hospital, Taipei 10002, Taiwan"},{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin 64041, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Chou","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10041, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Wei","family":"Liao","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu 30059, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Sheng","family":"Hung","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10002, Taiwan"},{"name":"Cardiovascular center, National Taiwan University Hospital, Taipei 10002, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10002, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8153-1441","authenticated-orcid":false,"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10002, Taiwan"},{"name":"Cardiovascular center, National Taiwan University Hospital, Taipei 10002, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"TAIPAI Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.amjms.2016.06.015","article-title":"Primary aldosteronism: Diagnosis and management","volume":"352","author":"Gyamlani","year":"2016","journal-title":"Am. J. Med Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11906-010-0134-2","article-title":"Prevalence and diagnosis of primary aldosteronism","volume":"12","author":"Rossi","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: The german conn\u2019s registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: A controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet. Diabetes Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"32103","DOI":"10.1038\/srep32103","article-title":"Long term outcome of aldosteronism after target treatments","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/HJH.0000000000001534","article-title":"Aldosterone induces left ventricular subclinical systolic dysfunction: A strain imaging study","volume":"36","author":"Chen","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2011.12.003","article-title":"Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma","volume":"221","author":"Lin","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"20862","DOI":"10.1038\/srep20862","article-title":"Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: Prospective study of 102 patients","volume":"6","author":"Liao","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000153339.27064.14","article-title":"Endothelial function: Cardiac events","volume":"111","author":"Lerman","year":"2005","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10741-016-9591-2","article-title":"Genomic and rapid effects of aldosterone: What we know and do not know thus far","volume":"22","author":"Hermidorff","year":"2017","journal-title":"Heart Fail. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.vh.2018.12.001","article-title":"Non-genomic effects of aldosterone","volume":"109","author":"Mihailidou","year":"2019","journal-title":"Vitam. Horm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.1996.03540140074032","article-title":"The 1996 albert lasker medical research awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide","volume":"276","author":"Furchgott","year":"1996","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","article-title":"Nitric oxide and cyclic gmp in cell signaling and drug development","volume":"355","author":"Murad","year":"2006","journal-title":"New Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: From marvel to menace","volume":"113","author":"Forstermann","year":"2006","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-biochem-050410-100030","article-title":"Structure and regulation of soluble guanylate cyclase","volume":"81","author":"Derbyshire","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K","article-title":"Molecular mechanism of cgmp-mediated smooth muscle relaxation","volume":"184","author":"Carvajal","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.RES.84.2.210","article-title":"Mechanism of nitric oxide-induced vasodilatation","volume":"84","author":"Cohen","year":"1999","journal-title":"Circ. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1074\/jbc.272.8.5063","article-title":"Cyclic gmp causes Ca2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase","volume":"272","author":"Lee","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"C358","DOI":"10.1152\/ajpcell.90645.2007","article-title":"Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo","volume":"295","author":"Mizuno","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"H328","DOI":"10.1152\/ajpheart.00132.2014","article-title":"Cimp synthesized by sgc as a mediator of hypoxic contraction of coronary arteries","volume":"307","author":"Chen","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/FJC.0000000000000167","article-title":"Hypoxic vasospasm mediated by cimp: When soluble guanylyl cyclase turns bad","volume":"65","author":"Gao","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/nm1119","article-title":"S-glutathiolation by peroxynitrite activates serca during arterial relaxation by nitric oxide","volume":"10","author":"Adachi","year":"2004","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbagen.2011.03.007","article-title":"S-nitrosylation-regulated gpcr signaling","volume":"1820","author":"Daaka","year":"2012","journal-title":"Biochim. Et Biophys. Acta (Bba) Gen. Subj."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molcel.2008.05.024","article-title":"S-nitrosylation of \u03b2-arrestin regulates \u03b2-adrenergic receptor trafficking","volume":"31","author":"Ozawa","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cell.2007.02.046","article-title":"Regulation of \u03b2-adrenergic receptor signaling by s-nitrosylation of g-protein-coupled receptor kinase 2","volume":"129","author":"Whalen","year":"2007","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/japplphysiol.00728.2004","article-title":"Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin","volume":"98","author":"Kellogg","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0006-291X(03)01086-6","article-title":"Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase a signaling pathway","volume":"306","author":"Bae","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1161\/01.CIR.0000066697.19571.AF","article-title":"Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells","volume":"107","author":"Li","year":"2003","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"C628","DOI":"10.1152\/ajpcell.1994.266.3.C628","article-title":"Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells","volume":"266","author":"Kuchan","year":"1994","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.niox.2010.08.003","article-title":"Direct, real-time measurement of shear stress-induced nitric oxide produced from endothelial cells in vitro","volume":"23","author":"Andrews","year":"2010","journal-title":"Nitric Oxide"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2796.2006.01621.x","article-title":"Endothelial mechanotransduction, nitric oxide and vascular inflammation","volume":"259","author":"Harrison","year":"2006","journal-title":"J. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1242\/jcs.01165","article-title":"Enos at a glance","volume":"117","author":"Sessa","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"H1819","DOI":"10.1152\/ajpheart.00214.2002","article-title":"Shear stress stimulates phosphorylation of enos at ser635 by a protein kinase a-dependent mechanism","volume":"283","author":"Boo","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1074\/jbc.M108789200","article-title":"Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at ser1179 by akt-independent mechanisms: Role of protein kinase a","volume":"277","author":"Boo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"E68","DOI":"10.1161\/hh1101.092677","article-title":"Phosphorylation of thr(495) regulates ca(2+)\/calmodulin-dependent endothelial nitric oxide synthase activity","volume":"88","author":"Fleming","year":"2001","journal-title":"Circ. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/01.HYP.0000226054.53527.bb","article-title":"Molecular mechanism of the inhibitory effect of aldosterone on endothelial no synthase activity","volume":"48","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1073\/pnas.95.16.9220","article-title":"Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors","volume":"95","author":"Kalyanaraman","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jsbmb.2008.03.005","article-title":"Aldosterone and the vascular system","volume":"109","author":"Cachofeiro","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.HYP.0000171479.36880.17","article-title":"Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats","volume":"46","author":"Cachofeiro","year":"2005","journal-title":"Hypertension"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/bjp.2008.200","article-title":"Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane a2 and prostacyclin","volume":"154","author":"Xavier","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.HYP.37.6.1444","article-title":"Et(a) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats","volume":"37","author":"Park","year":"2001","journal-title":"Hypertension"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"R1288","DOI":"10.1152\/ajpregu.00397.2010","article-title":"The interaction between endothelin-1 and nitric oxide in the vasculature: New perspectives","volume":"300","author":"Bourque","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000345243","article-title":"Vascular actions of aldosterone","volume":"50","author":"Briet","year":"2013","journal-title":"J. Vasc. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/HYPERTENSIONAHA.110.153619","article-title":"Epidermal growth factor receptor mediates the vascular dysfunction but not the remodeling induced by aldosterone\/salt","volume":"57","author":"Fassot","year":"2011","journal-title":"Hypertension"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.110.161653","article-title":"Gpr30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone","volume":"57","author":"Gros","year":"2011","journal-title":"Hypertension"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"C532","DOI":"10.1152\/ajpcell.00203.2012","article-title":"Aldosterone mediates its rapid effects in vascular endothelial cells through gper activation","volume":"304","author":"Gros","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm1545","article-title":"Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity","volume":"13","author":"Leopold","year":"2007","journal-title":"Nat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrm1128","article-title":"Rocks: Multifunctional kinases in cell behaviour","volume":"4","author":"Riento","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"H2112","DOI":"10.1152\/ajpheart.00016.2010","article-title":"Vascular hypertrophy-associated hypertension of profilin1 transgenic mouse model leads to functional remodeling of peripheral arteries","volume":"298","author":"Hassona","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4103\/0975-3583.74258","article-title":"The role of rhoa\/rho kinase pathway in endothelial dysfunction","volume":"1","author":"Yao","year":"2010","journal-title":"J. Cardiovasc. Dis. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/HYPERTENSIONAHA.114.05001","article-title":"Effect of aldosterone-producing adenoma on endothelial function and rho-associated kinase activity in patients with primary aldosteronism","volume":"65","author":"Matsumoto","year":"2015","journal-title":"Hypertension"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/HJH.0000000000001989","article-title":"Eplerenone improves endothelial function and arterial stiffness and inhibits rho-associated kinase activity in patients with idiopathic hyperaldosteronism: A pilot study","volume":"37","author":"Kishimoto","year":"2019","journal-title":"J. Hypertens."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0021-9150(02)00363-5","article-title":"Aldosterone induces contraction of the resistance arteries in man","volume":"166","author":"Romagni","year":"2003","journal-title":"Atherosclerosis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3317\/jraas.2002.013","article-title":"Lack of rapid aldosterone effects on forearm resistance vasculature in health","volume":"3","author":"Gunaruwan","year":"2002","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.HYP.0000083298.23119.16","article-title":"Rapid nongenomic effects of aldosterone on human forearm vasculature","volume":"42","author":"Schmidt","year":"2003","journal-title":"Hypertension"},{"key":"ref_60","first-page":"761","article-title":"Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system","volume":"86","author":"Schmidt","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.HYP.0000105111.06482.7E","article-title":"Rapid nongenomic aldosterone effects in the human forearm?","volume":"43","author":"Schmitt","year":"2004","journal-title":"Hypertension"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"N13","DOI":"10.1097\/00003246-200004001-00003","article-title":"Chemokine signaling in inflammation","volume":"28","author":"Keane","year":"2000","journal-title":"Crit. Care Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/HJH.0000000000000259","article-title":"Chronic aldosterone administration causes nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation","volume":"32","author":"Chrissobolis","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/en.2007-0864","article-title":"Aldosterone induces superoxide generation via rac1 activation in endothelial cells","volume":"149","author":"Iwashima","year":"2008","journal-title":"Endocrinology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.HYP.0000100443.09293.4F","article-title":"Reactive oxygen species in the vasculature: Molecular and cellular mechanisms","volume":"42","author":"Taniyama","year":"2003","journal-title":"Hypertension"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects ap-1 and nuclear factor-kappab activation in angiotensin ii-induced cardiac injury","volume":"37","author":"Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: Role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0895-7061(04)00811-8","article-title":"Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system","volume":"17","author":"Iglarz","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbrc.2003.11.173","article-title":"Nad(p)h oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats","volume":"313","author":"Park","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/HYPERTENSIONAHA.109.142422","article-title":"Reactive oxygen species, nadph oxidases, and hypertension","volume":"56","author":"Datla","year":"2010","journal-title":"Hypertension"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.yjmcc.2013.12.004","article-title":"The signaling pathway for aldosterone-induced mitochondrial production of superoxide anion in the myocardium","volume":"67","author":"Nolly","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/bbrc.1999.1771","article-title":"Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice","volume":"266","author":"Haseroth","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/me.2004-0469","article-title":"Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions","volume":"19","author":"Grossmann","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1210\/en.2006-1157","article-title":"Angiotensin ii receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: The possible role of local renin-angiotensin system","volume":"148","author":"Hirono","year":"2007","journal-title":"Endocrinology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1196\/annals.1420.022","article-title":"Mapping preconditioning\u2019s signaling pathways: An engineering approach","volume":"1123","author":"Downey","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1161\/01.CIR.0000039328.33137.6C","article-title":"Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: Effects of eplerenone","volume":"106","author":"Lacolley","year":"2002","journal-title":"Circulation"},{"key":"ref_78","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J. Lab. Clin. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis","volume":"93","author":"Young","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.ATV.17.6.1152","article-title":"Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats","volume":"17","author":"Benetos","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/HYPERTENSIONAHA.108.111815","article-title":"Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder","volume":"52","author":"Matsui","year":"2008","journal-title":"Hypertension"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1291\/hypres.28.447","article-title":"Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress","volume":"28","author":"Yoshida","year":"2005","journal-title":"Hypertens. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.HYP.0000176236.55322.18","article-title":"Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes","volume":"46","author":"Rude","year":"2005","journal-title":"Hypertension"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2016.02.034","article-title":"Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor","volume":"1637","author":"Dinh","year":"2016","journal-title":"Brain Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"F377","DOI":"10.1152\/ajprenal.00477.2013","article-title":"Renal mechanisms of salt-sensitive hypertension: Contribution of two steroid receptor-associated pathways","volume":"308","author":"Nishimoto","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/hyp.39.2.614","article-title":"Cardiac damage prevention by eplerenone: Comparison with low sodium diet or potassium loading","volume":"39","author":"Martinez","year":"2002","journal-title":"Hypertension"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/aps.2012.36","article-title":"The mineralocorticoid receptor-p38mapk-nfkappab or erk-sp1 signal pathways mediate aldosterone-stimulated inflammatory and profibrotic responses in rat vascular smooth muscle cells","volume":"33","author":"Zhu","year":"2012","journal-title":"Acta Pharm. Sin"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000180753.63183.95","article-title":"Aldosterone and angiotensin ii synergistically induce mitogenic response in vascular smooth muscle cells","volume":"97","author":"Min","year":"2005","journal-title":"Circ. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/01.CIR.0000131860.80444.AB","article-title":"Aldosterone potentiates angiotensin ii-induced signaling in vascular smooth muscle cells","volume":"109","author":"Mazak","year":"2004","journal-title":"Circulation"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/CIRCRESAHA.109.196576","article-title":"Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors","volume":"105","author":"Lemarie","year":"2009","journal-title":"Circ. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10157-011-0498-x","article-title":"Aldosterone stimulates nuclear factor-kappa b activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1","volume":"16","author":"Terada","year":"2012","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/en.2006-0965","article-title":"A direct effect of aldosterone on endothelin-1 gene expression in vivo","volume":"148","author":"Wong","year":"2007","journal-title":"Endocrinology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.CIR.0000051459.74466.46","article-title":"Endothelin-1 increases vascular superoxide via endothelin(a)-nadph oxidase pathway in low-renin hypertension","volume":"107","author":"Li","year":"2003","journal-title":"Circulation"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1073\/pnas.0804037106","article-title":"Aldosterone activates endothelial exocytosis","volume":"106","author":"Jeong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/HYPERTENSIONAHA.111.196832","article-title":"Aldosterone modulates endothelial permeability and endothelial nitric oxide synthase activity by rearrangement of the actin cytoskeleton","volume":"61","author":"Kirsch","year":"2013","journal-title":"Hypertension"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.ATV.0000097769.47306.12","article-title":"Regulation of superoxide anion production by nadph oxidase in monocytes\/macrophages: Contributions to atherosclerosis","volume":"24","author":"Cathcart","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.4049\/jimmunol.1600823","article-title":"Endothelial mapks direct icam-1 signaling to divergent inflammatory functions","volume":"198","author":"Dragoni","year":"2017","journal-title":"J. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1055\/s-2001-18579","article-title":"The endothelium as a metabolic and endocrine organ: Its relation with insulin resistance","volume":"109","author":"Waldhausl","year":"2001","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bja\/aeh163","article-title":"Physiology of the endothelium","volume":"93","author":"Galley","year":"2004","journal-title":"Br. J. Anaesth."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cvr\/cvy013","article-title":"Il-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis","volume":"114","author":"Chou","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"R1742","DOI":"10.1152\/ajpregu.90995.2008","article-title":"The role of aldosterone in mediating the dependence of angiotensin hypertension on il-6","volume":"297","author":"Sturgis","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000248135.97380.76","article-title":"Angiotensin ii induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism","volume":"48","author":"Luther","year":"2006","journal-title":"Hypertension"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3803\/EnM.2016.31.4.567","article-title":"Cardiac dysfunction in association with increased inflammatory markers in primary aldosteronism","volume":"31","author":"Lim","year":"2016","journal-title":"Endocrinol. Metab."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/01.hjh.0000170379.08214.5a","article-title":"Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: Role of the nfkappab\/ikappab system","volume":"23","author":"Cediel","year":"2005","journal-title":"J. Hypertens."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"III\u201327","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Chhabra, R.K. (2009). Endothelial Dysfunction\u2014A Predictor of Atherosclerosis. Internet J. Med. Update, 4.","DOI":"10.4314\/ijmu.v4i1.39872"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ahj.2011.06.015","article-title":"Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data","volume":"162","author":"Hillaert","year":"2011","journal-title":"Am. Heart J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MED.0b013e3283391989","article-title":"Aldosterone and inflammation","volume":"17","author":"Gilbert","year":"2010","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5830\/CVJA-2011-068","article-title":"Endothelial dysfunction: The early predictor of atherosclerosis","volume":"23","author":"Mudau","year":"2012","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_114","first-page":"27","article-title":"Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, and aldosterone antagonist","volume":"29","author":"Bauters","year":"1995","journal-title":"Cardiovasc. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00005344-200306000-00019","article-title":"Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein e-deficient mice","volume":"41","author":"Keidar","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","article-title":"Aldosterone administration to mice stimulates macrophage nadph oxidase and increases atherosclerosis development: A possible role for angiotensin-converting enzyme and the receptors for angiotensin ii and aldosterone","volume":"109","author":"Keidar","year":"2004","journal-title":"Circulation"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.ATV.0000204635.75748.0f","article-title":"Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation","volume":"26","author":"Suzuki","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/HYPERTENSIONAHA.107.104299","article-title":"Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability","volume":"51","author":"Imanishi","year":"2008","journal-title":"Hypertension"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2017.01.013","article-title":"Essential role of icam-1 in aldosterone-induced atherosclerosis","volume":"232","author":"Marzolla","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e000018","DOI":"10.1161\/JAHA.112.000018","article-title":"Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism","volume":"2","author":"McGraw","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","article-title":"Mineralocorticoid receptors in vascular function and disease","volume":"350","author":"McCurley","year":"2012","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijcard.2005.03.078","article-title":"Eplerenone suppresses neointimal formation after coronary stent implantation in swine","volume":"107","author":"Wakabayashi","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.HYP.0000078357.92682.EC","article-title":"Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling","volume":"42","author":"Pu","year":"2003","journal-title":"Hypertension"},{"key":"ref_124","first-page":"2454","article-title":"The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure","volume":"24","author":"Loufrani","year":"2010","journal-title":"Faseb J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/eurheartj\/eht095","article-title":"Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity","volume":"34","author":"Schafer","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.113.01803","article-title":"Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone\/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure","volume":"63","author":"Rickard","year":"2014","journal-title":"Hypertension"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"New Engl. J. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/CIRCULATIONAHA.104.504340","article-title":"Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair","volume":"111","author":"Rossig","year":"2005","journal-title":"Circulation"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2265.2008.03271.x","article-title":"Primary aldosteronism (pa) and endothelial progenitor cell (epc) bioavailability","volume":"69","author":"Verhovez","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/eurheartj\/ehq254","article-title":"Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans","volume":"32","author":"Thum","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1210\/jc.2011-1135","article-title":"Endothelial progenitor cells in primary aldosteronism: A biomarker of severity for aldosterone vasculopathy and prognosis","volume":"96","author":"Wu","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/HYPERTENSIONAHA.113.01273","article-title":"Aldosterone and vascular mineralocorticoid receptors: Regulators of ion channels beyond the kidney","volume":"63","author":"DuPont","year":"2014","journal-title":"Hypertension"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"F1289","DOI":"10.1152\/ajprenal.00247.2012","article-title":"Aldosterone-dependent and -independent regulation of the epithelial sodium channel (enac) in mouse distal nephron","volume":"303","author":"Nesterov","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00424-007-0341-0","article-title":"Aldosterone and amiloride alter enac abundance in vascular endothelium","volume":"455","author":"Sobczak","year":"2008","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00424-013-1356-3","article-title":"The role of enac in vascular endothelium","volume":"466","author":"Jeggle","year":"2014","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_136","first-page":"3652","article-title":"Long-term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndrome","volume":"27","author":"Druppel","year":"2013","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.118.11339","article-title":"Epithelial sodium channel in aldosterone-induced endothelium stiffness and aortic dysfunction","volume":"72","author":"Jia","year":"2018","journal-title":"Hypertension"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/FJC.0b013e318279ba20","article-title":"Endothelial small-conductance and intermediate-conductance kca channels: An update on their pharmacology and usefulness as cardiovascular targets","volume":"61","author":"Wulff","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCRESAHA.108.172379","article-title":"Modulation of endothelial cell kca3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries","volume":"102","author":"Dora","year":"2008","journal-title":"Circ. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.1073\/pnas.0801963105","article-title":"Functional architecture of inositol 1,4,5-trisphosphate signaling in restricted spaces of myoendothelial projections","volume":"105","author":"Ledoux","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/CIRCULATIONAHA.107.731679","article-title":"Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells","volume":"117","author":"Saliez","year":"2008","journal-title":"Circulation"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.108.846634","article-title":"Genetic deficit of sk3 and ik1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension","volume":"119","author":"Brahler","year":"2009","journal-title":"Circulation"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/01.RES.0000081980.63146.69","article-title":"Altered expression of small-conductance ca2+-activated k+ (sk3) channels modulates arterial tone and blood pressure","volume":"93","author":"Taylor","year":"2003","journal-title":"Circ. Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00424-010-0819-z","article-title":"Endothelial dysfunction and blood pressure alterations in k+-channel transgenic mice","volume":"459","author":"Kohler","year":"2010","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: Exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"Raposo","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Gould, S.J., and Raposo, G. (2013). As we wait: Coping with an imperfect nomenclature for extracellular vesicles. J. Extracell. Vesicles, 2.","DOI":"10.3402\/jev.v2i0.20389"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/cvr\/cvz021","article-title":"Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury","volume":"115","author":"Neves","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Lopez Andres, N., Tesse, A., Regnault, V., Louis, H., Cattan, V., Thornton, S.N., Labat, C., Kakou, A., Tual-Chalot, S., and Faure, S. (2012). Increased microparticle production and impaired microvascular endothelial function in aldosterone-salt-treated rats: Protective effects of polyphenols. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039235"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e001842","DOI":"10.1161\/JAHA.112.001842","article-title":"Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: Implications in vascular senescence","volume":"1","author":"Burger","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/HYPERTENSIONAHA.119.12944","article-title":"Characterization and gene expression analysis of serum-derived extracellular vesicles in primary aldosteronism","volume":"74","author":"Burrello","year":"2019","journal-title":"Hypertension"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/HYPERTENSIONAHA.119.13088","article-title":"Extracellular vesicles as biomarkers and biovectors in primary aldosteronism","volume":"74","author":"Neves","year":"2019","journal-title":"Hypertension"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.HYP.21.6.929","article-title":"Vasodilation to acetylcholine in primary and secondary forms of human hypertension","volume":"21","author":"Taddei","year":"1993","journal-title":"Hypertension"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","article-title":"Aldosterone induces acute endothelial dysfunction in vivo in humans: Evidence for an aldosterone-induced vasculopathy","volume":"103","author":"Farquharson","year":"2002","journal-title":"Clin. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin i\/angiotensin ii conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/hrt.2003.017368","article-title":"Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment","volume":"90","author":"Macdonald","year":"2004","journal-title":"Heart"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: Testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2147\/VHRM.S2769","article-title":"Measurement of endothelial function and its clinical utility for cardiovascular risk","volume":"4","author":"Kharbanda","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","article-title":"The assessment of endothelial function: From research into clinical practice","volume":"126","author":"Flammer","year":"2012","journal-title":"Circulation"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e30324","DOI":"10.5812\/ijem.30324","article-title":"Asymmetric dimethylarginin (adma) as a marker of endothelial dysfunction in primary aldosteronism","volume":"14","author":"Matrozova","year":"2016","journal-title":"Int. J. Endocrinol. Metab."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/jhh.2014.11","article-title":"Endothelial dysfunction in patients with primary aldosteronism: A biomarker of target organ damage","volume":"28","author":"Liu","year":"2014","journal-title":"J. Hum. Hypertens."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/01.CIR.0000129307.26791.8E","article-title":"Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism","volume":"109","author":"Nishizaka","year":"2004","journal-title":"Circulation"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e4175","DOI":"10.1097\/MD.0000000000004175","article-title":"Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease","volume":"95","author":"Lai","year":"2016","journal-title":"Medicine"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1210\/jc.2015-2752","article-title":"Aldosterone impairs vascular smooth muscle function: From clinical to bench research","volume":"100","author":"Chou","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41440-018-0093-6","article-title":"Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism","volume":"41","author":"Kishimoto","year":"2018","journal-title":"Hypertens Res"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/1470320314524996","article-title":"Hypokalemia correlated with arterial stiffness but not microvascular endothelial function in patients with primary aldosteronism","volume":"16","author":"Chang","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J Hypertens."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.amjhyper.2006.02.002","article-title":"Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension","volume":"19","author":"Strauch","year":"2006","journal-title":"Am. J. Hypertens."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ajh.2008.243","article-title":"Adrenalectomy improves arterial stiffness in primary aldosteronism","volume":"21","author":"Strauch","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"461","DOI":"10.33549\/physiolres.932344","article-title":"Peripheral arterial stiffness in primary aldosteronism","volume":"61","author":"Rosa","year":"2012","journal-title":"Physiol. Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"29984","DOI":"10.18632\/oncotarget.16269","article-title":"Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring kcnj5 mutations after adrenalectomy","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_173","first-page":"8","article-title":"Evaluation of the endopat as a tool to assess endothelial function","volume":"2012","author":"Moerland","year":"2012","journal-title":"Int. J. Vasc. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41440-018-0153-y","article-title":"Microvascular and macrovascular endothelial function in two different types of primary aldosteronism","volume":"42","author":"Kato","year":"2019","journal-title":"Hypertens Res"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/01.HYP.0000239236.12524.d3","article-title":"At the beginning of stiffening: Endothelial dysfunction meets \u201cpulsology\u201d","volume":"48","author":"Verdecchia","year":"2006","journal-title":"Hypertension"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.HYP.0000239206.64270.5f","article-title":"Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans","volume":"48","author":"McEniery","year":"2006","journal-title":"Hypertension"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/eurheartj\/ehi619","article-title":"Flow-mediated changes in pulse wave velocity: A new clinical measure of endothelial function","volume":"27","author":"Naka","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/HYPERTENSIONAHA.114.04636","article-title":"Kcnj5 mutations are the most frequent genetic alteration in primary aldosteronism","volume":"65","author":"Williams","year":"2015","journal-title":"Hypertension"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A meta-analysis of somatic kcnj5 k(+) channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/20\/5214\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:28:06Z","timestamp":1760189286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/20\/5214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":179,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["ijms20205214"],"URL":"https:\/\/doi.org\/10.3390\/ijms20205214","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,21]]}}}